Clinical Trials Browser

Phase 3 × CS-1003 × Clear all

NCT04194775 2025-12-11

A Study of Nofazinlimab (CS1003) in Subjects With Advanced Hepatocellular Carcinoma

Phase 3 Active not recruiting

Gastrointestinal

Carcinoma, Hepatocellular